GHK-Cu peptide claims on TikTok: what the science says

What did @eudranathaliabettio actually say?

Honestly? Not much that's medically coherent. The transcript is largely incoherent, reading as a garbled mix of construction or tech language, "restore it to other buildings," "make it easy and restore it," followed by a verbal loop that trails off entirely. There are no specific claims about GHK-Cu's mechanism, dosing, or benefits. The video is hashtagged with peptide-related terms including #ghkcu, but the spoken content doesn't match that framing in any meaningful way.

This creates a real problem for fact-checking: there's nothing substantive to evaluate. The hashtags suggest the creator intended to discuss GHK-Cu, a copper-binding peptide that appears naturally in human plasma and has a legitimate body of preclinical research behind it. But if there are claims being made, they're not in the transcript we have. Any analysis here is therefore based on what this creator likely intended to discuss, given the tags, not on what they demonstrably said.

Does the science back this up?

for GHK-Cu specifically, the research is genuinely interesting but largely preclinical. It would be wrong to say the science is strong enough to make confident therapeutic claims, and it would also be wrong to dismiss it as junk. The honest answer is: promising, but not proven in humans at scale.

GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) was first isolated by Loren Pickart in the early 1970s. Since then, research has pointed toward several plausible mechanisms. Pickart and Margolina (2018, Cosmetics) reviewed evidence suggesting GHK-Cu promotes collagen and elastin synthesis, activates antioxidant enzymes, and modulates hundreds of genes involved in tissue repair. Hong et al. (2001, Journal of Investigative Dermatology) showed wound-healing effects in animal models. Separately, Dou et al. (2022, Frontiers in Aging Neuroscience) examined GHK's potential neuroprotective effects, again mostly in vitro or animal contexts.

The limitation is consistent: most of this work hasn't been replicated in well-designed, adequately powered human clinical trials. Topical formulations have more published human data than injectable GHK-Cu, but even there the evidence is moderate at best.

What did they get wrong (or right)?

There's no specific scientific claim in this transcript to evaluate as right or wrong, which is itself a problem. A creator hashtagging a video with #ghkcu and #peptide is implicitly signaling expertise or information to their audience. If the audio is garbled, misleading, or accidentally misrepresents their intent, viewers still walk away with associations between the creator and peptide authority, without receiving any actual information.

This is worth naming plainly: in peptide content on TikTok, the framing often does as much work as the facts. Hashtags, aesthetics, and confident delivery move people toward purchasing decisions even when the actual spoken content is vague. The transcript here reads as either a technical glitch or a video that was auto-captioned from unrelated audio. Either way, no accurate or inaccurate claims can be credited or corrected.

What we can say is that GHK-Cu does have legitimate peer-reviewed interest behind it. A creator covering this topic accurately would mention its natural presence in human plasma, declining levels with age, and the distinction between topical versus systemic research bases.

What should you actually know?

GHK-Cu is one of the more studied peptides in the cosmetic and longevity space, which still doesn't mean the evidence justifies the hype around injectable use. Here's the actual state of play:

• Topical GHK-Cu has reasonable evidence for skin remodeling outcomes. Injectable or systemic use is far less studied in humans.
• GHK-Cu is not FDA-approved as a drug. Compounded versions exist and are sold through some telehealth platforms, but their purity, dosing, and bioavailability are not equivalent to what's been studied in research settings.
• The peptide appears safe in most studies, but "no reported harms" in small studies is not the same as an established safety profile.
• Anyone considering peptide therapy should be working with a licensed provider who can review their full health picture, not acting on TikTok content.

The real issue here isn't that GHK-Cu is dangerous or fraudulent. It's that the gap between "interesting preclinical data" and "you should inject this" is enormous, and social media content rarely acknowledges that gap honestly.